SFCC Sfbc (MM)

SFBC International, Inc. (NASDAQ: SFCC), a provider of drug development services to branded pharmaceutical, biotechnology, generic drug and medical device companies, today announced that Jeffrey P. McMullen, chief executive officer, will present at the Lehman Brothers Ninth Annual Global Healthcare Conference at 2:30 p.m. ET on Thursday, March 9, 2006. The conference will take place at The Loews Miami Beach Hotel in South Beach, FL. All interested parties can access a live audio Webcast of the presentation through the "Webcasts" section of SFBC's Web site at www.sfbci.com. The replay of the Webcast will be available within 48 hours of the live presentation and will remain available for 90 days following the conference. About SFBC International, Inc. SFBC International, Inc. provides early through late stage clinical drug development services to branded pharmaceutical, biotechnology, generic drug and medical device companies around the world. SFBC has more than 30 offices located in North America, Europe (including Central and Eastern Europe), South America, Asia, and Australia. In early clinical development services, SFBC specializes primarily in the areas of Phase I and early Phase II clinical trials and bioanalytical laboratory services, including early clinical pharmacology. SFBC also provides late stage clinical development services globally that focus on Phase II through IV clinical trials. SFBC also offers a range of complementary services, including data management and biostatistics, medical and scientific affairs, regulatory affairs and submissions, and clinical IT solutions. Additional information is available on SFBC's website at http://www.sfbci.com.